Merck exec heads pharma MBA program
Former Merck VP-Corporate Planning & Development Clifford Cramer will head Columbia Business School's MBA Healthcare & Pharmaceutical Management Program, the school announces Aug. 21. At Merck, Cramer oversaw strategic planning and external growth activities and reported to CEO Raymond Gilmartin. Most recently, he served as managing director of the healthcare investment banking groups of Merrill Lynch and J.P. Morgan...
You may also be interested in...
Taiwan’s JHL Biotech has rebranded itself as Eden Biologics at the same time as it has announced progress on clinical trials for its denosumab biosimilar candidate.
Starpharma's COVID-busting Viraleze antiviral nasal spray will soon be available across Europe, included the UK. But will it fall foul of local evidence requirements, for example in France, where the country's medicines agency has halted the sale of Pharma & Beauty (P&B) Group's COV-Defense spray until its efficacy against COVID has been confirmed by human-based studies?
Coronavirus Update: Moderna’s Variant-Targeting Vaccine Moves Into Trial, J&J Looks Set For US Authorization
A round up of COVID-19 developments, also including news on the EMA beginning a rolling review of Celltrion's antibody therapy, and progress for Novavax and Moderna in Japan.